glp-1 receptor agonists fatigue side effects Glucagon-like peptide-1 and muscle mass This One Mistake Puts GLP-1

The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033.

While weight loss effects can vary depending on the drug, studies show that all GLP-1 meds can result in an average weight loss of about 10.5 to 15.8 []

Here is what the evidence says about protecting your bones and muscle on GLP-1 therapy.

Few categories in modern medicine have captured the imagination of patients, physicians, and investors as quickly as GLP-1 receptor agonists (GLP-1s)

Frequently asked questions

Learn how to switch from tirzepatide to retatrutide safely